New York State Common Retirement Fund Acquires 27,114 Shares of Ralliant Corporation $RAL

New York State Common Retirement Fund boosted its holdings in Ralliant Corporation (NYSE:RAL) by 43.5% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 89,478 shares of the company’s stock after acquiring an additional 27,114 shares during the quarter. New York State Common Retirement Fund’s holdings in Ralliant were worth $3,913,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Dodge & Cox acquired a new position in Ralliant during the second quarter worth about $523,571,000. Viking Global Investors LP bought a new stake in shares of Ralliant during the 2nd quarter valued at approximately $257,200,000. State Street Corp acquired a new position in Ralliant during the 2nd quarter worth approximately $213,096,000. Flossbach Von Storch SE bought a new position in Ralliant in the 2nd quarter valued at approximately $198,077,000. Finally, Norges Bank bought a new position in Ralliant in the 2nd quarter valued at approximately $108,453,000.

Trending Headlines about Ralliant

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Analyst upgrades: Vertical Research upgraded Ralliant from “hold” to “buy” with a $45 price target, which supports near‑term upside expectations. The Fly: Vertical Research upgrade
• Positive Sentiment: Citigroup maintained a “buy” rating (but trimmed its PT to $51 from $61), which still implies meaningful upside and likely helped calm some selling pressure. Benzinga: Citigroup note
• Positive Sentiment: Quarterly results modestly beat: Q4 EPS of $0.69 (vs. $0.67 est.) and revenue of ~$554.6M (vs. $543M est.), showing underlying operational resilience despite the one‑time items. MarketBeat: Q4 results
• Neutral Sentiment: Company set 2026 revenue target of $2.1B–$2.2B (roughly in line with consensus), which supports the topline outlook but is tempered by other items below. BusinessWire: FY2026 outlook
• Negative Sentiment: Material non‑cash charge: the company recorded a $1.4B goodwill impairment in its Test & Measurement segment (EA Elektro‑Automatik), producing a large reported net loss and triggering the recent sharp selloff. MarketWatch: $1.4B impairment
• Negative Sentiment: Multiple law‑firm investigations and investor notices (Holzer & Holzer, Johnson Fistel, Block & Leviton) are underway into the impairment and disclosures, adding legal/exec‑risk uncertainty. GlobeNewswire: Investor alerts
• Negative Sentiment: Shares recently hit an all‑time low after the impairment and heavy losses were disclosed, which can pressure sentiment until clarity on write‑ups, integration and legal outcomes emerges. InsiderMonkey: All‑time low coverage

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on RAL shares. Morgan Stanley reaffirmed an “overweight” rating and set a $45.00 target price on shares of Ralliant in a research note on Friday. Royal Bank Of Canada cut their price objective on Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a report on Friday. Barclays upped their target price on Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Citigroup dropped their target price on Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a research report on Friday. Finally, Weiss Ratings cut Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Ralliant presently has a consensus rating of “Moderate Buy” and an average target price of $51.30.

Ralliant Stock Performance

NYSE RAL opened at $39.50 on Friday. The company has a market capitalization of $4.46 billion and a price-to-earnings ratio of 31.10. The company has a quick ratio of 1.03, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $57.02. The stock has a fifty day simple moving average of $51.52 and a 200 day simple moving average of $46.72.

Ralliant (NYSE:RAL) last announced its earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. The firm’s revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be issued a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 annualized dividend and a yield of 0.5%. Ralliant’s dividend payout ratio (DPR) is presently 15.75%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.